HSBC set a €42.00 ($48.84) target price on Siemens Healthineers (ETR:SHL) in a research note released on Wednesday. The brokerage currently has a buy rating on the stock.

Other analysts have also recently issued reports about the stock. Commerzbank set a €43.00 ($50.00) price target on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Friday, October 19th. Berenberg Bank set a €42.00 ($48.84) price target on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Monday, November 5th. Citigroup set a €42.50 ($49.42) price target on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Thursday, September 27th. Goldman Sachs Group set a €34.50 ($40.12) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Tuesday, September 25th. Finally, Sanford C. Bernstein set a €41.00 ($47.67) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Tuesday, September 25th. Fourteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of €38.17 ($44.39).

Shares of Siemens Healthineers stock opened at €36.22 ($42.12) on Wednesday.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

See Also: What is a Leveraged Buyout (LBO)?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.